This page was translated automatically from Turkish. Read the original

This page is an AI-assisted Turkish summary of the study presented at the 26th World Congress of Psychiatry. The study belongs to the presenting authors; please refer to the original source when citing it.

EV0352

Diabetes distress and comorbid depression: a case report of a young woman with type 1 diabetes

DIABETES DISTRESS AND COMORBID DEPRESSION: A CASE REPORT OF A YOUNG WOMAN WITH TYPE 1 DIABETES

In a young woman with type 1 diabetes, recurrent depression over several years worsened during pregnancy and the postpartum period, culminating in a suicide attempt; combined pharmacotherapy and structured psychosocial interventions led to marked improvement within five months.

The aim of this presentation is to illustrate the risk of depression and the clinical complexity in a young woman with type 1 diabetes (T1D). The poster notes that psychosocial difficulties, particularly depressive disorders, are more prevalent in individuals with T1D than in the general population, with meta-analytic data indicating clinically significant depressive symptoms in up to one-third of young people with T1D. The case concerns a woman who was diagnosed with T1D at age 21 and started on insulin therapy; two years later, she developed a moderate depressive episode and took escitalopram for three years. Her subsequent course was characterized by recurrent depressive symptoms, partial remissions, and poor treatment adherence. At age 28, she experienced a marked exacerbation during pregnancy and the postpartum period, requiring antidepressant treatment for six months. Two years after giving birth, she developed severe depressive symptoms accompanied by suicidal ideation and attempted suicide by insulin overdose. Following hospitalization, combined pharmacotherapy consisting of an antipsychotic, an anxiolytic, and a mood stabilizer was administered alongside structured psychosocial interventions and optimization of glycemic control; marked clinical improvement was observed within five months. The authors emphasize that biological and psychosocial mechanisms contribute to the risk of depression in T1D, that psychosocial screening is needed at diagnosis and annually thereafter, and that integrated multidisciplinary care is essential for improving both psychiatric and metabolic outcomes.

All WCP 2026 summaries